New publications
Scientists have created a cure for premature ejaculation
Last reviewed: 30.06.2025
All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
Recently, a representative of the American pharmaceutical company Ampio Pharmaceuticals proudly announced the successful completion of the last stage of clinical trials of the drug Zertane, which provides a man with the ability to have a long sexual intercourse.
Thus, soon, according to Ampio Pharmaceuticals, the company will apply to the relevant regulatory agency of the European Union with a request to register the drug and allow its sale in EU countries - for some reason, the company does not plan to enter the American market with it yet.
“Analysis of the data obtained from the last stage of clinical trials of Zertan showed that the drug’s effectiveness significantly exceeds even our most optimistic expectations,” Ampio Pharmaceuticals said in a press release.
There is no need to take Zertan in courses – it is enough to take one tablet some time before a romantic meeting.
It remains to mention that Zertan is nothing more than tramadol hydrochloride. For this reason, it will be sold in pharmacies only with a doctor's prescription, since the drug is an opioid narcotic analgesic.
According to some data, premature ejaculation affects 23% of the male population aged 18 to 75 years.
[